Fluorodeoxyglucose-PET in the management of malignant melanoma.


FDG-PET is of limited use in patients with early-stage disease without nodal or distant metastases (stage I-II), because sentinel node biopsy is much more sensitive in detecting microscopic lymph node metastases. Because of the high tumor-to-background ratio, FDG-PET can highlight metastases at unusual sites that are easily missed with conventional imaging… (More)


Cite this paper

@article{Kumar2005FluorodeoxyglucosePETIT, title={Fluorodeoxyglucose-PET in the management of malignant melanoma.}, author={Rakesh Kumar and Ayşe Mavi and Gonca Gul Bural and Abass Alavi}, journal={Radiologic clinics of North America}, year={2005}, volume={43 1}, pages={23-33} }